Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulforaphane in Biochemical Recurrence of Prostate Cancer
NCT01228084Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Nov 2010
- Primary completion
- May 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulforaphane in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started Nov 2010; status: completed.
02
Drugs
sulforaphane
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01228084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01228084.